ScripTakeda Pharmaceutical Co. Ltd. appears to have made important early strides with Qdenga in Brazil, where the dengue tetravalent vaccine has been rolled out in a public program, even as the Japanese c
ScripTakeda Pharmaceutical Co. Ltd. ’s live, attenuated tetravalent dengue vaccine Qdenga (TAK-003) has received its global first approval, in Indonesia, for the prevention of disease caused by any serotyp